Health economic aspects of pharmaceutical research and development decisions
Course information here
Early phase assessment requires special skills in health technology assessment, economic modeling, and market research. Developers should explore realistic pricing assumptions and business models of these technologies before moving ahead or investing in a development program. The course – in addition to providing insights into theory – will mainly be based on case studies. Participants will construct economic models to judge the valuebased price of investigational medical products, and evaluate their expected net present value to support indication selection and go, no-go decisions.
Zoltán Kaló MD, MSc, PhD
Professor of Health Economics
HOW TO APPLY?
Registration deadline for applicants
from Semmelweis University:
21 October, 2020
For registration download the
application from here:
and send your filled application to: